This study is in progress, not accepting new patients
Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Head and Neck Cancer Carcinoma, Squamous Cell Squamous Cell Carcinoma of Head and Neck Nivolumab Ipilimumab Nivolumab and Ipilimumab
Lead Scientist at UCSF
- Alain Algazi
Associate Professor, Medicine. Authored (or co-authored) 60 research publications.